Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

Diabetes care pilot examines greater links between secondary care and community pharmacy

The diabetes care pilot aims to implement some of the recommendations made in the Royal Pharmaceutical Society’s diabetes policy, which was published on 10 July 2019.

Mahendra Patel

Source: Courtesy of Mahendra Patel

Mahendra Patel announced the diabetes care pilot on 28 September 2019 at a conference held by the British Association of Physicians of Indian Origin

A new pilot scheme will assess whether greater community pharmacy involvement in diabetes care helps improve the overall health of patients.

The objective of the diabetes care pilot, which will run in two community pharmacies in Weston-super-Mare, Somerset, is to find out if closer links between secondary care and community pharmacy help meet national targets for care of patients with diabetes, including regular foot and eye checks, which are included in the overhauled pharmacy quality scheme.

Patients attending these pharmacies will also be offered lifestyle advice, medicines adherence support and help with using blood glucose meters.

The pilot was announced by Mahendra Patel, a member of the Royal Pharmaceutical Society (RPS) English Pharmacy Board, at a conference held by the British Association of Physicians of Indian Origin on 28 September 2019.

Under the scheme, patients who currently attend a diabetes clinic in secondary care will be referred, with their consent, to a community pharmacy for support with management of their health.

Patel and Parag Singhal, a consultant diabetologist and stakeholder in the development of the RPS’s diabetes policy, which was published on 10 July 2019, worked on developing the pilot. Patel said the scheme is a way to implement some of the recommendations including the full integration of pharmacists 

“Around 60% of diabetes patients are non-adherent or partially adherent to medicines”, Singhal told The Pharmaceutical Journal. 

“Opportunistic advice from pharmacists, who know the importance of taking medicines regularly, could improve adherence and reduce complications. 

“Through this pilot, we hope that patients will get continued reinforcement of the importance of medicines adherence, alongside lifestyle advice, to improve glycaemic control — leading to better lives. It’s about trying to convert the RPS’s diabetes policy into practical experience.

The pilot will begin on 15 October 2019. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207134

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.